Articles

The era of diversification has begun. Goldman says it has further to run.

“Diversify to amplify” is the call from Goldman strategists.

Mamdani’s victory could be a loss for investors in these New York City real-estate stocks

Worries about higher taxes for companies and ultrawealthy people and more regulations is hurting the stocks of some New York-focused real-estate investment trusts.

Lowering pay for federal jobs is bad for workers — and bad for America

Going forward, the government will have to pay more — not less — to be competitive

I’m 68 and leaving my job for grad school. What should I do about health insurance? 

“I don’t have enough years to retire or get medical coverage through the state after I quit work.”

Cheerios parent General Mills will sacrifice some profit to drive sales, and the stock is dropping

General Mills will look to keep prices low, with a focus on sales growth.

Here’s one stock-market forecast you can bank on: No one will ever have a crystal ball

Evaluate a forecaster’s credibility before buying in — and don’t mistake anecdotes for data.

Why more big companies like Sherwin-Williams are talking about immigration on their earnings calls

As President Donald Trump and his fellow Republicans in Congress take tougher stances on immigration issues, there has been a surge in mentions of immigration in quarterly earnings calls of S&P 500 companies.

Here’s how AI will help investors, according to Robinhood’s CEO

Tenev said that AI represents the next frontier for investors and the financial firms they do business with.

The next great WFH trend will be ‘War from Home,’ says this strategist

The idea that warfare is conducted without troops actually on foreign soil will require investment into the defense sector — and not just with the big companies, says this strategist.

My friend asked me to pay $1,600 for her son’s prom-night limo. Has the world gone mad?

“He is handsome and popular and has maintained good grades. My friend wanted to do something special.”

After key conference, here’s how the race to a $150 billion weight-loss drug market is shaping up

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

Cows on the roof? How to build a real-estate empire, Barbara Corcoran style.

Real estate mogul Barbara Corcoran has opened up about the controversial methods she used to achieve success —from quirky costume parties to staging publicity stunts.
1 17 18 19 20 21 2,158